Back to Results
First PageMeta Content
Health / Metabolic syndrome / Insulin resistance / Prediabetes / Impaired fasting glucose / Impaired glucose tolerance / Diabetes mellitus / Insulin / Gestational diabetes / Diabetes / Endocrine system / Medicine


Clinical Review Article Series Editor: A. Maziar Zafari, MD, PhD, FACC The Metabolic Syndrome and Glucose Intolerance Lawrence S. Phillips, MD
Add to Reading List

Open Document

File Size: 215,62 KB

Share Result on Facebook

City

Schmidt / Harris / Atlanta / /

Company

European Diabetes Epidemiology Group / Diabetes Prevention Program Research Group / Proc Natl Acad Sci U S A / Furukawa / ADP / DECODE Study Group / HP / /

Continent

Europe / /

Country

United States / /

Currency

pence / CAD / /

Event

Person Communication and Meetings / Product Issues / /

Facility

National Institute of Diabetes / /

IndustryTerm

energy / Diabetes Prevention Program / mitochondrial electron-transport chain / lipid peroxidation products / research / glycolytic processing / health care systems / Diabetes Care / Treatment of the metabolic syndrome / /

MedicalCondition

glucose intolerance / Postprandial hyperglycemia / marked obesity / postchallenge/postprandial hyperglycemia / hyperinsulinemia / sustained hyperglycemia / insulin resistance syndrome / progressively severe insulin resistance / associated insulin resistance / Relative insulin deficiency / Aside from obesity / obesity / higher insulin resistance / Glucose Intolerance Lawrence S. Phillips / both prediabetes / coronary heart disease / hypoglycemia / FACC The Metabolic Syndrome / Mitochondrial dysfunction / insulin resistance / hypertension / increased insulin resistance / disease / glucose-induced beta cell dysfunction / endothelial dysfunction / hyperglycemia / causes pancreatic beta cell dysfunction / early beta-cell dysfunction / Mechanisms Of The Development Of Beta-cell Dysfunction With The Metabolic Syndrome Systemic Oxidative Stress Obesity / unrecognized diabetes / dyslipidemia / diabetes / prediabetes / cardiovascular disease / post-challenge hyperglycemia / metabolic syndrome / tumor necrosis / myocardial infarction / overall obesity / diabetes mellitus / heart attack / incident diabetes / beta cell dysfunction / tumor ne crosis factor / mg/dL Diabetes / previously unrecognized diabetes / coronary artery disease / beta-cell dysfunction / fatty liver / early diabetes / inflammation / both cardiovascular disease / overt diabetes / undiagnosed diabetes / syndrome / human disease / acute hyperglycemia / early glucose intolerance / be aimed at decreasing insulin resistance / /

NaturalFeature

When islet / /

Organization

World Health Organization / Diabetologia Hospital / National Institute of Diabetes / Digestive and Kidney Diseases / American Diabetes Association / Centers for Disease Control and Prevention / Emory University School of Medicine / Division of Cardiology / UCP-2 Hospital / Division of Endocrinology and Metabolism / /

Person

Mary K. Rhee / Lawrence S. Phillips / Arch Intern / A. Maziar Zafari / /

Position

Stern MP / Bindokas VP / Clinical Review Article Series Editor / associate professor and director / Cardiovascular Training Program / / Hospital Physician / insulin messenger / physician / VP / Kuznetsov / Skulachev VP / Starkov AA / professor of medicine / associate professor and director / Cardiovascular Training Program / instructor / /

Product

Bal / pioglitazone / acetylcysteine / repaglinide / adenosine / nateglinide / rosiglitazone / glucose tolerance / /

ProvinceOrState

Georgia / /

Technology

apoptosis / gene expression / CVD / CAD / /

URL

www.turner-white.com / /

SocialTag